SRARP and thyroid gland carcinoma: In contrast, SRARP differential expression showed significant negative values between −0.06 and −5.47 (P < 0.02) in head and neck, renal clear cell, renal papillary, lung squamous cell, rectal, stomach, and thyroid cancers in addition to sarcoma (Fig. 3A and Table 2).